๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Quzhou
Clinical trial register · China

Clinical Trials in Quzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Quzhou

14 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis
NCT07530224Immune Checkpoint Inhibitor-Induced Dermatitis
Shixiu Wu
Phase 2
35
Quzhou
2026-03-25
Recruiting
Utility of Whole Genome Sequencing in Fetuses With Abnormal Ultrasound Findings
NCT07606989Prenatal Diagnosis, Fetal Diseases
Women's Hospital School Of Medicine Zhejiang University
Observational
1,000
Hangzhou, Huzhou, Quzhou, Shaoxing
2026-03-12
Recruiting
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
NCT07307560Hypoxia, Esophageal Cancer, Gastric Cancer (Diagnosis), Obstructive Sleep Apnea (OSA)
Zhejiang University
Not applicable
600
Hangzhou, Jiaxing, Quzhou
2025-12-21
Recruiting
Exploratory Study on the Role of Vitamin C in Promoting Health in Middle-Aged and Elderly Adults
NCT06794255Ageing
Peking University Third Hospital
Not applicable
400
Nanchang, Quzhou, Beijing
2025-04-02
Recruiting
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
NCT07022223Marginal Zone Lymphoma(MZL)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
51
Hangzhou, Dongyang, Huzhou, Jiaxing, Lishui, Ningbo, Quzhou, Shaoxing
2025-03-11
Recruiting
JAK Inhibitors for Solid Malignant Tumor Patients With Immune Checkpoint Inhibitors-related Dermatitis: A Open-lable, Single Arm, Phase IIa Trial
NCT06715982Immune Checkpoint Inhibitors (ICI)-Related Dermatitis
Shixiu Wu
Phase 2
35
Quzhou
2024-12-31
Recruiting
The Hi-tACS on Cognitive Function in Patients With Schizophrenia
NCT06470516Schizophrenia
Sir Run Run Shaw Hospital
Not applicable
100
Hanzhou, Quzhou
2024-04-01
By invitation
Gut Microbiota and Metabolic Development in Early Childhood: A 3-Year Follow-Up Study
NCT07762729Gut Microbiota, Early Child Development
Children's Hospital of Fudan University
Observational
1,000
Yiyang, Nantong, Shanghai, Baoji, Quzhou
2023-11-16
Active, closed
Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis
NCT06825312Japanese Encephalitis Vaccine
Liaoning Chengda Biotechnology CO., LTD
Phase 4
600
Jiaxing, Jinhua, Ningbo, Quzhou
2023-11-11
Recruiting
Intervention of Nicotinamide Mononucleotide in Middle-aged and Elderly People
NCT06592859Aging, NMN
People's Hospital of Quzhou
Not applicable
240
Quzhou
2023-08-23
Recruiting
Radiotherapy Combined With Endostatin and Capecitabine for NPC
NCT05514275Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 2
41
Hangzhou, Jiaxing, Jinhua, Lishui, Ningbo, Quzhou
2022-08-01
Active, closed
V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071)
NCT05450705Papillomavirus Infections
Merck Sharp & Dohme LLC
Phase 3
1,500
Quzhou, Taizhou
2022-07-22
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-china/city/quzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Quzhou.

How many clinical trials are recruiting in Quzhou?

10 of the 14 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 2 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Quzhou), 14 studies
PhaseStudiesRecruitingShare
Not applicable5535.7%
Phase 24328.6%
Observational2114.3%
Phase 3107.1%
Phase 4107.1%
Phase EARLY_PHASE1117.1%

Most active sponsors

Lead sponsors with the most studies (Quzhou)
Lead sponsorStudiesRecruiting
People's Hospital of Quzhou22
Shixiu Wu21
Bo Yan11
Children's Hospital of Fudan University10
Liaoning Chengda Biotechnology CO., LTD10
Merck Sharp & Dohme LLC10
Peking University Third Hospital11
Second Affiliated Hospital, Zhejiang University, School of Medicine11
Sir Run Run Shaw Hospital11
Women's Hospital School Of Medicine Zhejiang University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.